Literature DB >> 21151800

ALLOREACTIVE T LYMPHOCYTES CULTURED FROM LIVER TRANSPLANT BIOPSIES: ASSOCIATIONS OF HLA SPECIFICITY WITH CLINICOPATHOLOGICAL FINDINGS.

Bernd H Markus1, A Jake Demetris, Susan Saidman, John J Fung, Adriana Zeevi, Thomas E Starzl, Rene J Duquesnoy.   

Abstract

Lymphocyte cultures grown from liver allograft biopsies were shown to exhibit alloreactivity towards donor cells as measured by primed lymphocyte testing (PLT). The PLT specificity was determined in assays using HLA typed panel cells and/or by inhibition testing with HLA specific monoclonal antibodies. Certain cultures exhibited PLT specificity towards class I HLA antigens of the donor, whereas others were specific for class II HLA antigens or recognized mixtures of class I and II antigens. These PLT specificity patterns were compared with clinical, histological and laboratory findings on the liver transplant patients at the time of the biopsy. Biopsies yielding class I specific PLT cells were taken generally during the earlier posttransplant period, whereas class II specific cells were grown from later biopsies. There was no significant correlation of the PLT specificity towards class I vs II antigens with the levels of total or direct bilirubin, serum glutamate oxaloacetic transaminase (SGOT), and serum glutamate pyruvate transaminase (SGPT), although a trend towards higher values was noted for biopsies presenting with a class II specific infiltrate. However, the levels of gamma glutamyl transpeptidase (GGTP) and alkaline phosphatase (AP) were significantly increased when biopsies yielded class II specific rather than class I specific PLT cells. Biopsy histology showed more damage to bile duct epithelium in association with class II PLT specificity whereas intense but often reversible infiltrates were found in biopsies yielding class I specific cells. The elevated GGTP and AP levels are probably related to the interaction of class II specific T cells with bile duct epithelium, which has been shown to express induced class II HLA antigens on their cell surface.

Entities:  

Year:  1988        PMID: 21151800      PMCID: PMC3000170     

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  29 in total

Review 1.  Monoclonal antibodies for analysis of the HLA system.

Authors:  F M Brodsky; P Parham; C J Barnstable; M J Crumpton; W F Bodmer
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

Review 2.  Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction.

Authors:  T E Starzl; M Ishikawa; C W Putnam; K A Porter; R Picache; B S Husberg; C G Halgrimson; G Schroter
Journal:  Transplant Proc       Date:  1974-12       Impact factor: 1.066

3.  Humoral rejection of rat hepatic transplants by passive transfer of serum.

Authors:  S J Knechtle; P C Kolbeck; S Tsuchimoto; A Coundouriotis; F Sanfilippo; R R Bollinger
Journal:  Transplant Proc       Date:  1987-02       Impact factor: 1.066

4.  HLA histocompatibility and liver transplant survival.

Authors:  B H Markus; J J Fung; R D Gordon; M Vanek; T E Starzl; R J Duquesnoy
Journal:  Transplant Proc       Date:  1987-08       Impact factor: 1.066

5.  Two populations of Ia-like molecules on a human B cell line.

Authors:  L A Lampson; R Levy
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

6.  Liver transplantation against T cell-positive warm crossmatches.

Authors:  S Iwatsuki; B S Rabin; B W Shaw; T E Starzl
Journal:  Transplant Proc       Date:  1984-12       Impact factor: 1.066

7.  Increased lymphocyte adherence to human arterial endothelial cell monolayers in the context of allorecognition.

Authors:  Y L Colson; B H Markus; A Zeevi; R J Duquesnoy
Journal:  J Immunol       Date:  1990-04-15       Impact factor: 5.422

8.  Liver transplantation across ABO blood groups.

Authors:  R D Gordon; S Iwatsuki; C O Esquivel; A Tzakis; S Todo; T E Starzl
Journal:  Surgery       Date:  1986-08       Impact factor: 3.982

9.  Hepatitis B virus and HLA antigen display in the liver during chronic hepatitis B virus infection.

Authors:  L Montano; G C Miescher; A H Goodall; K H Wiedmann; G Janossy; H C Thomas
Journal:  Hepatology       Date:  1982 Sep-Oct       Impact factor: 17.425

10.  Characterization of in vivo-activated allospecific T lymphocytes propagated from human renal allograft biopsies undergoing rejection.

Authors:  T G Mayer; A A Fuller; T C Fuller; A I Lazarovits; L A Boyle; J T Kurnick
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

View more
  3 in total

1.  Recognition of major histocompatibility complex antigens on cultured human biliary epithelial cells by alloreactive lymphocytes.

Authors:  S L Saidman; R J Duquesnoy; A Zeevi; J J Fung; T E Starzl; A J Demetris
Journal:  Hepatology       Date:  1991-02       Impact factor: 17.425

2.  Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect?

Authors:  B H Markus; R J Duquesnoy; R D Gordon; J J Fung; M Vanek; G Klintmalm; C Bryan; D Van Thiel; T E Starzl
Journal:  Transplantation       Date:  1988-09       Impact factor: 4.939

3.  Functional characteristics of lymphocytes propagated from a human multivisceral allograft.

Authors:  Jonathan D K Trager; Adriana Zeevi; Ronald Jaffe; Marc I Rowe; Satoru Todo; Thomas E Starzl; Rene J Duquesnoy
Journal:  Clin Transplant       Date:  1990       Impact factor: 2.863

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.